Vonoprazan-containing Dual and Triple Therapies are Non-inferior to Bismuth-quadruple Therapy for Helicobacter pylori Eradication: A Single-center, Prospective, Open-label, Real-World Study

Efficacy of the two Vo-containing regimens was comparable and non-inferior to the BQT in this region, and could serve as the first-line regimen for H. pylori eradication, and reduced use of one antibiotic per each patient treatment in real-world clinical application.

Authors

Institutions

Publication Details

Journal
Journal of Gastrointestinal and Liver Diseases
Published
2025-09-26
DOI
https://doi.org/10.15403/jgld-6183
Citations
2
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
4.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vonoprazan-containing Dual and Triple Therapies are Non-inferior to Bismuth-quadruple Therapy for Helicobacter pylori Eradication: A Single-center, Prospective, Open-label, Real-World Study

Kuan Li, Shiyu Shi, Qin Yan, Amr Mekky et al.
2 citations
Journal of Gastrointestinal and Liver Diseases
Helicobacter pylori-related gastroenterology studies
4.01
article

Vonoprazan-containing Dual and Triple Therapies are Non-inferior to Bismuth-quadruple Therapy for Helicobacter pylori Eradication: A Single-center, Prospective, Open-label, Real-World Study

Kuan Li, Shiyu Shi, Qin Yan, Amr Mekky, Songze Ding, Ruo‐Bing Hu, Lida Zhang, Qiao‐Qiao Shao, Jing Ma, Chen Zhang, Tingting Liu, Lu Xu, Xiao-Ting Li, Xinhui Fang, Shushu Song, Wenjing Zhang, Ya‐Bin Qi, Wei Xiao, Guo-Hong Yang
article en
2 citations

Abstract

Efficacy of the two Vo-containing regimens was comparable and non-inferior to the BQT in this region, and could serve as the first-line regimen for H. pylori eradication, and reduced use of one antibiotic per each patient treatment in real-world clinical application.

Journal of Gastrointestinal and Liver DiseasesVol. 34(3)
The Fifth People's Hospital of Anyang (CN), Henan Provincial People's Hospital (CN), First Affiliated Hospital of Henan University (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 6%
Helicobacter pylori-related gastroenterology studies
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Vonoprazan-containing Dual and Triple Therapies are Non-inferior to Bismuth-quadruple Therapy for Helicobacter pylori Eradication: A Single-center, Prospective, Open-label, Real-World Study — Kuan Li, Shiyu Shi, et al. · Journal of Gastrointestinal and Liver Diseases (2025) | TGRS Research Map | TGRS